Debt-to-equity in % of NeuBase Therapeutics, Inc. from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
NeuBase Therapeutics, Inc. quarterly Debt-to-equity history and change rate from Q1 2012 to Q3 2023.
  • NeuBase Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2023 was 65 %, a 130% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

NeuBase Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2023 65 +37 +1.3% 30 Sep 2023
Q2 2023 52 +28 +1.2% 30 Jun 2023
Q1 2023 38 +19 +95.9% 31 Mar 2023
Q4 2022 33 +16 +92.6% 31 Dec 2022
Q3 2022 28 +14 +91.6% 30 Sep 2022
Q2 2022 23 +11 +90.5% 30 Jun 2022
Q1 2022 19 +9 +89.9% 31 Mar 2022
Q4 2021 17 +5 +37.5% 31 Dec 2021
Q3 2021 14 -2 -12.8% 30 Sep 2021
Q2 2021 12 -10 -44.6% 30 Jun 2021
Q1 2021 10 -42 -80.1% 31 Mar 2021
Q4 2020 12 -45 -77.8% 31 Dec 2020
Q3 2020 17 -72 -80.8% 30 Sep 2020
Q2 2020 22 +104 30 Jun 2020
Q1 2020 52 +31 +1.4% 31 Mar 2020
Q4 2019 57 +47 +4.7% 31 Dec 2019
Q3 2019 89 +77 +6.3% 30 Sep 2019
Q2 2019 -81 -96 -6.5% 30 Jun 2019
Q1 2019 21 +3 +17% 31 Mar 2019
Q4 2018 10 -14 -58.7% 31 Dec 2018
Q3 2018 12 -11 -46.5% 30 Sep 2018
Q2 2018 14 -7 -31.9% 30 Jun 2018
Q1 2018 18 -3 -12% 31 Mar 2018
Q4 2017 24 +9 +62.9% 31 Dec 2017
Q3 2017 22 +8 +58% 30 Sep 2017
Q2 2017 21 +9 +76.4% 30 Jun 2017
Q1 2017 21 +11 +1.1% 31 Mar 2017
Q4 2016 14 +6 +61% 31 Dec 2016
Q3 2016 14 +3 +29.8% 30 Sep 2016
Q2 2016 12 -1 -7.7% 30 Jun 2016
Q1 2016 10 -7 -42.2% 31 Mar 2016
Q4 2015 9 -15 -61.8% 31 Dec 2015
Q3 2015 11 -10 -46.7% 30 Sep 2015
Q2 2015 13 -7 -33.9% 30 Jun 2015
Q1 2015 17 +8 +80% 31 Mar 2015
Q4 2014 24 +17 +2.4% 31 Dec 2014
Q3 2014 20 -2 -10.6% 30 Sep 2014
Q2 2014 20 -14 -40.9% 30 Jun 2014
Q1 2014 9 -105 -91.5% 31 Mar 2014
Q4 2013 7 -341 -98% 31 Dec 2013
Q3 2013 23 +779 30 Sep 2013
Q2 2013 34 +226 30 Jun 2013
Q1 2013 114 +271 31 Mar 2013
Q4 2012 347 31 Dec 2012
Q3 2012 -755 30 Sep 2012
Q2 2012 -191 30 Jun 2012
Q1 2012 -156 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.